🇺🇸 FDA
Patent

US 7799789

Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity

granted A61PA61P1/00A61P17/00

Quick answer

US patent 7799789 (Heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity) held by Pharmacopeia Drug Discovery, Inc. expires Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pharmacopeia Drug Discovery, Inc.
Grant date
Tue Sep 21 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 16 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
37
CPC classes
A61P, A61P1/00, A61P17/00, A61P17/06, A61P19/02